PP
AXSM icon

PDT Partners’s Axsome Therapeutics AXSM Stock Holding History

PDT Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Hold
2,100
– – 0.03% 397
2026
Q1 		$355K Sell
2,100
-1,477
-41% -$255K 0.02% 450
2025
Q4 		$653K Buy
+3,577
New +$499K 0.04% 387
2025
Q2 		– Sell
-51,199
Closed -$5.97M – 692
2025
Q1 		$5.97M Buy
51,199
+47,004
+1,120% +$5.35M 0.42% 42
2024
Q4 		$355K Sell
4,195
-7,506
-64% -$690K 0.03% 539
2024
Q3 		$1.05M Buy
+11,701
New +$1.02M 0.09% 353
2022
Q4 		– Sell
-8,397
Closed -$375K – 642
2022
Q3 		$375K Sell
8,397
-59,270
-88% -$2.96M 0.06% 521
2022
Q2 		$2.59M Buy
+67,667
New +$2.14M 0.23% 117

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PDT Partners's AXSM Position: Q2 2026 in Review

PDT Partners held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 2,100 shares worth $514K. The position accounts for 0.03% of the portfolio, ranked #397.

PDT Partners first reported a position in AXSM in Q2 2022 and has held it in 8 quarters since. The position peaked at $5.97M in Q1 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • PDT Partners held 2,100 shares of Axsome Therapeutics worth $514K as of Q2 2026.
  • PDT Partners left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up 0.03% of PDT Partners's portfolio in Q2 2026, its #397 holding.
  • PDT Partners first reported a position in Axsome Therapeutics in Q2 2022 and has held it in 8 quarters since.
  • PDT Partners's Axsome Therapeutics position peaked at $5.97M in Q1 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.